James Tartaglia

USPTO Granted Patents = 32 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 4.5

ph-index = 17

Forward Citations = 916(Granted Patents)

Location History:

Schenectady, NY (US) (1995 - 2011)
Aurora, CA (US) (2012)
Aurora, CA (2006 - 2014)
Nazareth, PA (US) (2017)
Toronto, CA (2019 - 2022)

Company Filing History:

17 out of 34

Virogenetics Corporation

Consejo Superior De Investigaciones Cientificas

patents

4. 3 out of 1,730

Arizona State University

Aventis Pasteur Limited

patents

7. 2 out of 2

Connaught Technology Corporation

patents

8. 2 out of 261

Arizona Board of Regents, a Body Corporate

patents

9. 2 out of 525

Ludwig Institute for Cancer Research Limited

patents

10. 1 out of 145

Connaught Laboratories Limited

patents

11. 1 out of 1

Academisch Zikenhuis Leiden

patent

12. 1 out of 25

Centre Hospitalier Universitaire Vaudois

patents

13. 1 out of 183

Universitéde Montreal

patents

14. 1 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

15. 1 out of 832,718

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2025

Loading Chart...

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12331307 - Modified immunization vectors (2025-06-17),

2. 11345928 - Modified immunization vectors (2022-05-31),

3. 10370679 - Modified immunization vectors (2019-08-06),

4. 9670506 - Modified immunization vectors (2017-06-06),

5. 8911991 - Multi-antigen vectors of melanoma (2014-12-16),

6. 8257717 - Immunogenic polypeptides encoded by MAGE minigenes and uses thereof (2012-09-04),

7. 8017590 - Method of inducing and/or enhancing an immune response to tumor antigens (2011-09-13),

8. 7851212 - Immunogenic polypeptides encoded by MAGE minigenes and uses thereof (2010-12-14),

9. 7771729 - Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors (2010-08-10),

10. 7255862 - ALVAC/FIV constructs (2007-08-14),

11. 7144578 - Poxvirus-rabies recombinants and compositions and methods employing the recombinants (2006-12-05),

12. 6780407 - Pox virus comprising DNA sequences encoding CEA and B7 antigen (2004-08-24),

13. 6596279 - Immunodeficiency recombinant poxvirus (2003-07-22),

14. 6537594 - Vaccina virus comprising cytokine and/or tumor associated antigen genes (2003-03-25),

15. 6309647 - Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants (2001-10-30),

Title: The Innovative Mind of James Tartaglia

Introduction: James Tartaglia, a brilliant inventor hailing from Aurora, CA, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: James Tartaglia's most recent patents include a cutting-edge virtual reality headset that revolutionizes the gaming industry, a solar-powered device for sustainable energy solutions, and a smart home automation system for enhanced convenience.

Career Highlights: With a career spanning over two decades, James Tartaglia has established himself as a pioneer in the tech world. His early work on wearable technology paved the way for future advancements in the industry. He has also been recognized for his research in artificial intelligence and machine learning.

Collaborations: Throughout his career, James Tartaglia has collaborated with leading tech companies, research institutions, and universities to bring his innovative ideas to life. His partnerships have led to the development of products that have had a lasting impact on society.

Conclusion: James Tartaglia's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His contributions to the world of technology continue to inspire and shape the future of innovation.

This text is generated by artificial intelligence and may not be accurate.